Premier Biomedical Valuation
| BIEI Stock | USD 0.0004 0.0002 33.33% |
Premier Biomedical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Premier Biomedical from analyzing the company fundamentals such as Shares Outstanding of 999.98 M, price to earning of 0.07 X, and Return On Asset of -1.54 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Premier Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Premier Biomedical is based on 3 months time horizon. Increasing Premier Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Premier Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Premier Pink Sheet. However, Premier Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.0E-4 | Real 3.28E-4 | Hype 4.9E-4 | Naive 4.72E-4 |
The intrinsic value of Premier Biomedical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Premier Biomedical's stock price.
Estimating the potential upside or downside of Premier Biomedical helps investors to forecast how Premier pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Premier Biomedical more accurately as focusing exclusively on Premier Biomedical's fundamentals will not take into account other important factors: Premier Biomedical Total Value Analysis
Premier Biomedical is currently forecasted to have valuation of 1.6 M with market capitalization of 4.3 M, debt of 160.75 K, and cash on hands of 71.2 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Premier Biomedical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.6 M | 4.3 M | 160.75 K | 71.2 K |
Premier Biomedical Investor Information
The company recorded a loss per share of 0.01. Premier Biomedical last dividend was issued on the 27th of June 2018. The entity had 1:250 split on the 27th of June 2018. Premier Biomedical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Premier Biomedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Premier Biomedical has an asset utilization ratio of 14.15 percent. This signifies that the Company is making $0.14 for each dollar of assets. An increasing asset utilization means that Premier Biomedical is more efficient with each dollar of assets it utilizes for everyday operations.Premier Biomedical Ownership Allocation
Premier Biomedical owns a total of 999.98 Million outstanding shares. Roughly 97.64 pct. of Premier Biomedical outstanding shares are held by general public with 2.36 % owned by insiders and only 0.0 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Premier Biomedical Profitability Analysis
The company reported the previous year's revenue of 14.28 K. Net Loss for the year was (374.47 K) with profit before overhead, payroll, taxes, and interest of 1.42 K.About Premier Biomedical Valuation
An absolute valuation paradigm, as applied to Premier Pink Sheet, attempts to find the value of Premier Biomedical based on its fundamental and basic technical indicators. By analyzing Premier Biomedical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Premier Biomedical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Premier Biomedical. We calculate exposure to Premier Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Premier Biomedical's related companies.Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania. Premier Biomedical is traded on OTC Exchange in the United States.
8 Steps to conduct Premier Biomedical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Premier Biomedical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Premier Biomedical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Premier Biomedical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Premier Biomedical's revenue streams: Identify Premier Biomedical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Premier Biomedical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Premier Biomedical's growth potential: Evaluate Premier Biomedical's management, business model, and growth potential.
- Determine Premier Biomedical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Premier Biomedical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Premier Biomedical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 262.1 M | |
| Retained Earnings | -17.1 M |
Complementary Tools for Premier Pink Sheet analysis
When running Premier Biomedical's price analysis, check to measure Premier Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Premier Biomedical is operating at the current time. Most of Premier Biomedical's value examination focuses on studying past and present price action to predict the probability of Premier Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Premier Biomedical's price. Additionally, you may evaluate how the addition of Premier Biomedical to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |